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As clinicians and researchers in traumatic brain injury and neurodegeneration we are 
concerned by the tone of reporting on chronic traumatic encephalopathy (CTE) that has 
developed in the past decade, highlighted in a recent article in the New York Times1. 
Misleading reporting can have unintended, negative consequences and we call for 
balance from the medical and scientific communities and the media when communicating 
on issues related to CTE.  
 
Contrary to common perception, the clinical syndrome of CTE has not yet been fully 
defined2, its prevalence is unknown and the neuropathological diagnostic criteria are no 
more than preliminary3. Crucially, we have incomplete understanding of the extent or 
distribution of pathology required to produce neurological dysfunction or to distinguish 
disease from normality, with the neuropathologic changes of CTE reported in apparently 
asymptomatic individuals4.5. Finally, although commonly quoted, there remains no 
consensus agreement on staging the severity of CTE pathology. In short, a single focus 
of the pathology implicated in CTE is not yet sufficient evidence to define disease.  
 
Recognizing limitations of the diagnostic process in human pathology, pathologists are 
careful to note that they are merely providing an opinion; acknowledging that another 
pathologist might reasonably reach a different conclusion on the same case6. In 
diagnoses where the criteria for assessment and reporting are established by broad 
consensus, the expectation is that variance in opinion is minimised. At this time, however, 
while CTE diagnostic criteria remain far from established, it is to be expected that there 
will be discordance in opinions on individual cases1.   
 Unfortunately, the uncertainties around the clinical syndrome and the pathological 
definition of CTE are not acknowledged adequately in much of the current research 
literature or related media reporting, which at times has resembled ‘science by press 
conference’7. Too often an inaccurate impression is portrayed that CTE is clinically 
defined, its prevalence is high and pathology evaluation is a simple ‘positive’ or ‘negative’ 
decision. This distorted reporting on CTE may have dire consequences. Specifically, 
individuals with potentially treatable conditions, such as depression or post-traumatic 
stress disorder, might make decisions on their future based on a misplaced belief that 
their symptoms inevitably herald an untreatable, degenerative brain disease culminating 
in dementia. 
 
We propose that the principle of ‘first, to do no harm’ is employed when communicating 
on CTE, whatever the platform. In particular, the many remaining uncertainties should 
always be acknowledged. Otherwise, there is a distinct risk of doing very real harm. 
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